Previous 10 | Next 10 |
Neurocrine Biosciences to Present at the Bank of America 2021 Healthcare Conference PR Newswire SAN DIEGO , May 4, 2021 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Bank of America 2021 Healthcare Conference at 11:00 a.m....
Neurocrine Biosciences Supports Mental Health Month and Tardive Dyskinesia Awareness Week - Mental Health Advocacy Community Recognizes and Over 40 States Declare First Week of May (2-8) Tardive Dyskinesia Awareness Week to Raise Awareness of this Burdensome and Often Misunderst...
Neurocrine Biosciences (NBIX) and Sentia Medical Sciences have entered into a research collaboration to discover novel, long-acting corticotropin-releasing factor ((CRF)) receptor antagonist peptide therapeutics.The collaboration will leverage Sentia’s proprietary peptide-based platfor...
SAN DIEGO, April 26, 2021 (GLOBE NEWSWIRE) -- Sentia Medical Sciences Inc. today announced that they have entered into a research collaboration with Neurocrine Biosciences, Inc. (Nasdaq: NBIX) aimed at discovering novel, long-acting corticotropin-releasing factor (CRF) receptor antagonist p...
Palm Beach, FL – April 22, 2021 – There are more than 600 types of neuro-disorders affecting the brain, spine, or nerves. Although some prevalent disorders such as cerebral stroke, Alzheimer’s disease, Parkinson’s disease, brain tumors, and epilepsy, are well-stu...
Neurocrine Biosciences Announces Appointment of Johanna Mercier to Board of Directors PR Newswire SAN DIEGO , April 16, 2021 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the appointment of Johanna Mercier to its Board of Directo...
Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2021 Financial Results Conference Call and Webcast Scheduled for Wednesday, May 5 PR Newswire SAN DIEGO , April 14, 2021 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) ...
Neurocrine Biosciences to Present Data from its Neurology Portfolio at the American Academy of Neurology's 73rd 2021 Virtual Meeting PR Newswire SAN DIEGO , April 8, 2021 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it wil...
Do You Have These Trending Biotech Stocks On Your Watchlist This Week? Biotech companies play a major role in advancing longevity and medicine, even more so as we recover from the coronavirus pandemic. It is this importance that made biotech stocks a major hit among investors, a...
Are These The Best Health Care Stocks To Buy Before April 2021? No matter the state of the world, the health care industry will likely continue to work towards improving our quality of life. With this being the case, it would make sense then that investors are turning to health ca...
News, Short Squeeze, Breakout and More Instantly...
Neurocrine Biosciences Inc. Company Name:
NBIX Stock Symbol:
NASDAQ Market:
Neurocrine Biosciences Inc. Website:
A look at the top 10 most actives in the United States Redhill Biopharma Ltd. (RDHL) rose 41.5% to $0.5434 on volume of 82,457,301 shares FSD Pharma Inc. (HUGE) rose 9.8% to $0.1109 on volume of 60,485,300 shares NVIDIA Corporation (NVDA) rose 2.3% to $119.75 on volume of 54,756,180 shares ...
Neurocrine Biosciences Reports Second Quarter 2024 Financial Results and Raises 2024 INGREZZA Sales Guidance PR Newswire INGREZZA ® (valbenazine) Second Quarter Net Product Sales of $580 Million Representing 32% Year-Over-Year Growth INGREZZA ...
Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules to Ease Administration for Patients Experiencing Dysphagia or Difficulty Swallowing PR Newswire SAN DIEGO , July 18, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX...